+1,201.4%
LNG vs GSK
+1,058.9%
+142.5%
-98.9%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | GSK | Excess | Alpha |
|---|---|---|---|---|
| 1D | -1.8% | -1.3% | -0.5% | -1.4% |
| 7D | -2.6% | -3.1% | +0.5% | -1.7% |
| 30D | +3.7% | -0.9% | +4.6% | +3.8% |
| 3M | +8.5% | -4.2% | +12.7% | +9.5% |
| 6M | +20.2% | -1.6% | +21.8% | +19.9% |
| YTD | +54.0% | +2.6% | +51.4% | +50.1% |
| 1Y | +40.9% | +6.2% | +34.7% | +35.7% |
| 3Y | +75.9% | +55.0% | +20.9% | +46.1% |
| 5Y | +190.4% | +42.8% | +147.6% | +143.3% |
| 10Y | +712.3% | +102.1% | +610.2% | +491.7% |
| All | +1,201.4% | +1,058.9% | +142.5% | +961.9% |
Cumulative growth
Daily Returns
Daily percentage return beside GSK.
Daily Out/Under-Performance
Portfolio return minus GSK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling